University of Maryland School of Medicine logo
Emergency Medicine
All Departments
UMSOM Assistant
UMEM Educational Pearls
  • Home
  • Departments
  • Emergency Medicine
  • CME
  • UMEM Educational Pearls
  • CME
  • Courses and Conferences
  • Free Open Access Medical Education
  • UMEM Educational Pearls

Search

201-220 of 555 results with category "Pediatrics"

Previous  |  1 |  ... |  6 |  7 |  8 |  9 |  10 |  11 |  12 |  13 |  14 |  15 |  16 |  ... |  28 |  Next

Title: Pediatric Cervical Spine Injuries

Category: Pediatrics

Posted: 12/29/2017 by Rose Chasm, MD (Updated: 7/21/2026)

Children less than 8 years, and especially infants, are more susceptible to upper cervical spine injury.  Moreover, validated decision rules for suspected cervical spine injury imaging have not been proven to be as sensitive or specific for children less than 8 years of age.

The pediatric cervical spine has greater elasticity of the ligamentous structures, while the cartilaginous structures are less calcified. An infant's neck musculature is underdeveloped, with a disproportionally large head.  These factors increase the risk of cervical spine injury, and can make it difficult to properly place protective cervical collars in infants while assessing them for injury. 

In very young children, consider placing padding under the shoulders to prevent abnormal flexion that can occur with placement of a cervical collar, and consider having a lower threshold to image if mechanism history or exam is concerning.

Children are not little adults!  Clinicians must acknowledge the anatomic differences, varying age-related ability to cooperate with examination, pediatric specific injury mechanisms, and decreased reliability of validated decision rules for imaging in children, especially when younger than 8 years old.

Show References

Murray BL, Cordle RJ: Pediatric Trauma, in Walls RM, Hockberger RS, Gausche-Hill M, et al (eds): Rosen’s Emergency Medicine: Concepts and Clinical Practice, ed 9. Philadelphia, Elsevier 2018, (Ch) 165:p 2042-2057.

Leonard JR, Jaffe DM, Kuppermann N, et al. Cervical spine injury patterns in children. Pediatrics 2014; 133:e1179.

 



Title: What is the ideal observation time for a patient with croup who has received racemic epinephrine?

Category: Pediatrics

Keywords: Croup, epinephrine, discharge, observation (PubMed Search)

Posted: 12/15/2017 by Jenny Guyther, MD (Updated: 7/21/2026)

The peak age for croup is 6 months to 3 years.  The cornerstone of treatment is corticosteroids, traditionally dexamethasone.  With oral administration, the peak onset is 1-2 hours. Steroids shorten the duration of symptoms, reduce the need for nebulized epinephrine and decrease the need for intubation.

Racemic epinephrine has been used for moderate to severe croup and can show an improvement in patient symptoms for up to 120 minutes.  There is little evidence to suggest how long to observe the patient for recurrence of symptoms after racemic epinephrine was given.  Previous studies have suggested both 2 and 4 hour observation.

299 patients were included in this study.  136 patients were observed for 3.1 to 4 hours.  In the 3.1 to 4 hour group, 21 (7%) failed treatment, 19 of those patients required admission and 2 returned within 24 hours.  No patients who were discharged home after 4 hours returned to the emergency department within 24 hours.

Bottom Line: Consider a 4 hour period of observation after giving racemic epinephrine in order to decrease bounce backs.

Show References

Smith S, Giordano K, Thompson A and DePiero A.  Failure of Outpatient Management With Different Observation Times After Racemic Epinephrine for Croup.  Clinical Pediatrics.  Epub ahead of print.  Accessed October 2017.



Title: Are viral upper respiratory tract infections an important risk factor for the development of acute otitis media? (submitted by Brian Parker, MD)

Category: Pediatrics

Keywords: URI, AOM, wait-and-see, antibiotic stewardship (PubMed Search)

Posted: 11/24/2017 by Mimi Lu, MD

As we are approaching the winter in the northern hemisphere, the number of visits for ear pain or respiratory symptoms are expected to increase.  The occurrence of acute otitis media (AOM) will also increase, but are these two disease processes related?

Drs. Heikkinen and Chonmaitree published a systematic review of previously reported studies regarding the correlation of these two disease processes (1).  As far back as 1990, studies have shown that up to 94% of pediatric patients diagnosed with AOM have concomitant upper respiratory infection (URI) type symptoms at time of diagnosis (2).   The viral infections most commonly associated with AOM are respiratory syncytial virus, influenza virus, and adenovirus (3).

The most commonly taught risk factors for developing AOM include young age, male gender, multiple siblings, day care attendance, and passive smoking.  These factors are also related to the development of upper respiratory symptoms, and the development of AOM should be thought of as a complication of the upper respiratory infection (4). 

Koivunen et al noted the highest incidence of AOM at day 3 after the onset of an URI, and the median time to diagnosis was day 4 (5). If you see a patient in day 2-4 of an URI, who has started to develop an ear effusion, but not clinical AOM, you may want to consider a “Wait-to-see” treatment option if the patient meets treatment criteria (https://em.umaryland.edu/educational_pearls/2049/).

Show References

(1) Heikkinen T, Chonmaitree T. Importance of Respiratory Viruses in Acute Otitis Media. Clinical Microbiology Reviews. 2003;16(2):230-241.

 (2) Arola M, Ruuskanen O, Ziegler T, Mertsola J, Näntö-Salonen K, Putto-Laurila A, Viljanen MK, Halonen P. Pediatrics. 1990 Dec; 86(6):848-55.
 
(3) Henderson FW, Collier AM, Sanyal MA, Watkins JM, Fairclough DL, Clyde WA Jr, Denny FW, N Engl J Med. 1982 Jun 10; 306(23):1377-83.
 
(4) Daly KA, Brown JE, Lindgren BR, Meland MH, Le CT, Giebink GS. Pediatrics. 1999 Jun; 103(6 Pt 1):1158-66.
 
(5) Koivunen, P., T. Kontiokari, M. Niemelä, T. Pokka, and M. Uhari. 1999. Time to development of acute otitis media during an upper respiratory tract infection in children. Pediatr. Infect. Dis. J. 18:303-305.


Title: Pediatric marijuana ingestion

Category: Pediatrics

Keywords: Marijuana, symptoms, overdose (PubMed Search)

Posted: 11/17/2017 by Jenny Guyther, MD (Updated: 7/21/2026)

In the US, there are an estimated 22.2 million users of cannabis based on the 2015 National Survey on Drug Use and Health.  The incidence of unintentional cannabis ingestion has increased in states that have legalized medical and recreational marijuana.  The cited article reviewed of 44 articles involving unintentional cannabis ingestion in children younger than 12 years.

The majority of intoxications were through cannabis resins followed by cookies and joints.

Lethargy was the most common presenting sign followed by ataxia.  Tachycardia, mydriasis and hypotonia were also noted.  Rarer but more serious presentations included respiratory depression and seizures.

Show References

Richards JR, Smith NE, Moulin AK.  Unintentional Cannabis Ingestion in Children: A Systemic Review.  The Journal of Pediatrics.  2017.  Epub ahead of print.



Title: Pediatric ARDS continued...

Category: Pediatrics

Keywords: ARDS, oxygenation index, OI, PALICC, acute lung injury, respiratory distress, PARDS (PubMed Search)

Posted: 10/27/2017 by Mimi Lu, MD

Some pediatric practitioners have adopted the oxygenation index (OI) ([FiO2 × mean airway pressure (Paw) × 100]/ PaO2) or oxygen saturation index (OSI) ([FiO2 × Paw × 100]/ SpO2) to assess hypoxemia in children instead of P/F ratios because of the less standardized approach to positive pressure ventilation in children relative to adults. 

OI can be used in pediatric patients to define severity of Acute Respiratory Distress Syndrome (ARDS) in patients receiving invasive mechanical ventilation and assess for potential ECMO treatment. 

In contrast, the P/F ratio should be used to diagnose Pediatric ARDS for patients receiving noninvasive continuous positive airway pressure [CPAP] or bilevel positive airway pressure [BiPAP]) with a minimum CPAP of 5 cm H2O.

Oxygen Index (OI) = FiO2 x MAP x 100
                                 ---------------------
                                         PaO2

  • Mild ARDS: 4 ≤ OI ≤ 8
  • Moderate ARDS: 8 ≤ OI < 16
  • Severe ARDS: OI ≥ 16
  • OI < 25: good outcome
  • OI 25-40: >40% mortality
  • OI > 40: Consider ECMO

Show References

1) Trachsel D, McCrindle BW, Nakagawa S, Bohn D. Oxygenation index predicts outcome in children wtih acute hypoxemic respiratory failure. Am J Respir Crit Care Med. 2005 Jul 15;172(2):206-11.
 
2) Pediatric Acute Respiratory Distress Syndrome: Consensus Recommendations from the Pediatric Acute Lung Injury Consensus Conference.  Pediatric Acute Lung Injury Consensus Conference Group. Pediatr Crit Care Med. 2015 Jun;16(5):428-39


Title: What is the best anti-emetic for children with vomiting?

Category: Pediatrics

Keywords: Vomiting, pediatric, medication (PubMed Search)

Posted: 10/20/2017 by Jenny Guyther, MD

Within the first hour after administration, ondosterone, metoclopramide and bromopride were equally efficacious.  At the 6 hour and 24 hour period after receiving the initial dose of medication, ondansetron was statistically superior to bromopride (not available in the US) and metoclopramide.  There were no reported side effects in the ondansetron group (including diarrhea or sedation).

Show Additional Information

This was a randomized control trial of children 1 year to 12 years seen in the pediatric emergency department in Brazil for vomiting and given intramuscular bromopride (0.15mg/kg to a maximum of 10 mg), metoclopramide (0.15mg/kg to a maximum of 10 mg), or ondansetron (0.15mg/kg to a maximum of 8 mg).  175 children were included.

Show References

Epifanio et al.  Bromopride, metoclopramide, or ondansetron for the treatment of vomiting in the emergency in the pediatric emergency department: a randomized control trial.  J Pediatr 2017.  Article in Press.

 



Title: Blunt Renal Trauma in pediatrics (submitted by Elizabeth England, MD)

Category: Pediatrics

Keywords: Trauma, hematuria, kidney injury (PubMed Search)

Posted: 10/13/2017 by Mimi Lu, MD

Pediatric patients are at a higher risk of blunt renal injury due to multiple anatomic features, include relatively less protective perinephric fat and surrounding musculature, and larger size of the kidneys in relation to the abdomen compared to their adult counterparts (1). For this reason, it is important to keep a high clinical suspicion for renal injury in the pediatric patient with blunt abdominal trauma, particularly in those with lower rib fractures, direct injury, flank ecchymosis and/or tenderness, rapid deceleration injury, or other significant traumatic mechanism (2). Despite the risk of radiation exposure, the preferred imaging modality for the diagnosis of renal injury in pediatric patients is computed tomography (similar to adults). Studies evaluating the utility of renal ultrasound have demonstrated poor sensitivity with a decreased likelihood of diagnosing low-grade injuries. While ultrasound may be a useful screening tool to evaluate for severe injury, it should not be used to rule out traumatic injury (1). Take home point: Keep a high suspicion for renal injury in pediatric patients with blunt abdominal trauma and confirm the diagnosis with computed tomography of the abdomen and pelvis with contrast.

Show References

(1) Fraser, J.D., Aguayo, P., Ostlie, D.J. et al. Pediatr Surg Int (2009) 25: 125. https://doi.org/10.1007/s00383-008-2316-4 (2) Gerstenbluth RE, Spirnak JP, Elder JS. Sports participation and high grade renal injuries in children. J Urol 2002; 168:2575.


Title: Risky Business in Bronchiolitis

Category: Pediatrics

Keywords: Pediatrics, Bronchiolitis, Respiratory Decompensation, Risk factors (PubMed Search)

Posted: 10/6/2017 by Megan Cobb, MD

Bronchiolitis season will soon be upon us. Here are some risk factors for children under 2 y/o with bronchiolitis, who may be more likely to suffer respiratory decompensation:

1. Age under 9 months

2. Black race

3. Hypoxia documented in the ED

4. Persisent accessory muscle use. 

Bottom Line: Consider providing respiratory support sooner than later in bronchiolitic infants with risk factors for decompensation. For HFNC, start at 1.5 - 2.0 L/kg/min, and titrate to work of breathing and  02 saturations. 

_______________________________________________________________________________

Pathophysiology: Bronchiolitis is a disease process that leads to inflammation of lower airways, causing bronchiolar edema, epithelial hyperplasia, mucus plugging, and air trapping or atelectasis. Common viral causes include RSV, Human Metapneumovirus, Rhinovirus, Influenza, and Parainfluenza. 

Clinical Course: For most strains, the disease course is often 5-7 days with the worst days being 3-5. The disease process can last longer, especially in neonates. The predominant presenting symptoms are often rhinorrhea, low grade fevers, and cough, but apnea can be the primary symptom in younger infants. As a result of increased work of breathing, PO feeding tolerance decreases and leads to dehydration. 

Treatment: Primarily supportive care with suctioning, hydration, supplemental oxygen via standard NC, HFNC, and in severe cases BiPAP, CPAP or intubation. Trial of bronchodilator is often used, but there is no role for repeated bronchodilator use if no benefit is seen in pre and posttreatment respiratory effort. Hypertonic saline is not recommended for routine use in the ED. Corticosteroids have no role for routine use in viral bronchiolitis, either.

Show Additional Information

Show References

Dadlez NM, et al. Risk Factors for Respiratory Decompensation Among Healthy Infants with Bronchiolitis. Hosp Pediatr. 2017 Sep; 7(9): 530-535.
 
Schlapbach LJ, et al. Burden of disease and change in practice in critically ill infants with bronchiolitis. Euro Resp J. 2017; 49.
 
Ralston SL, et al. Clinical Practice Guideline: The Diagnosis, Management, and Prevention of Bronchiolitis. Pediatrics. Nov 2014; 134(5).
 
Weiler T, et al. The Relationship between High Flow Nasal Cannula Flow Rate and Effort of Breathing in Children. J Pediatr. Oct 2017; 189: 66-71. 

 



Title: Pediatric Acute Respiratory Distress Syndrome (ARDS)

Category: Pediatrics

Keywords: ARDS, oxygenation index, OI, PALICC, acute lung injury (PubMed Search)

Posted: 9/22/2017 by Mimi Lu, MD (Updated: 10/27/2017)

Since the first description of acute respiratory distress syndrome (ARDS), various consensus conferences (including American-European Consensus Conference (AECC) and the Berlin Conference) have produced definitions focused on adult lung injury but have limitations when applied to children. 

This prompted the organization of the Pediatric Acute Lung Injury Consensus Conference (PALICC), comprised of  27 experts, representing 21 academic institutions and eight countries.  The goals of the conference were 1) to define pediatric ARDS (PARDS); 2) to offer recommendations regarding therapeutic support; and 3) to identify priorities for future research in PARDS.

Although there were several recommendations from the group, some notable ones, in contrast to the Berlin definition focused on adults, include: 1) use the Oxygenation Index (or, if an arterial blood gas is not available, the Oxygenation Severity Index) rather than the P/F ratio; 2) elimination of the requirement for “bilateral” pulmonary infiltrates (may be unilateral or bilateral) 3) elimination of  specific age criteria for PARDS.

Tune in next month for pearls on management for children with PARDS...

Show References

Pediatric Acute Respiratory Distress Syndrome: Consensus Recommendations from the Pediatric Acute Lung Injury Consensus Conference.  Pediatric Acute Lung Injury Consensus Conference Group. Pediatr Crit Care Med. 2015 Jun;16(5):428-39

Collaborators: Jouvet P, Thomas NJ, Wilson DF, Erickson S, Khemani R, Zimmerman J, Dahmer M, Flori H, Quasney M, Sapru A, Cheifetz IM, Rimensberger PC, Kneyber M, Tamburro RF, Curley MA, Nadkarni V, Valentine S, Emeriaud G, Newth C, Carroll CL, Essouri S, Dalton H, Macrae D, Lopez-Cruces Y, Quasney M, Santschi M, Watson RS, Bembea M.



Title: Adverse outcomes during procedural sedation associated with upper respiratory tract infections

Category: Pediatrics

Keywords: Sedation, URI, adverse events (PubMed Search)

Posted: 9/15/2017 by Jenny Guyther, MD (Updated: 7/21/2026)

Elective surgeries with general anesthesia are often cancelled when the child has an upper respiratory tract infection.  What are the adverse events when procedural sedation is used when the child has an upper respiratory tract infection?

Recent and current URIs were associated with an increased frequency of airway adverse events (AAE).  The frequency of AAEs increased from recent URIs, to current URIs with thin secretions to current URIs with thick secretions.   Adverse events not related to the airway were less likely to have a statistically significant difference between the URI and non-URI groups

AAEs for children with no URI was 6.3%.  Children with URI with thick/green secretions had AAEs in 22.2% of cases.  Children with URIs did NOT have a significant increase in the risk of apnea or need for emergent airway intervention.  The rates of AAEs, however, still remains low regardless of URI status.

 

 

Show Additional Information

Data was collected on over 83,000 patients retrospectively from a voluntary database, The Pediatric Sedation Research Consortium.  Children with URIs (no fever) who underwent procedural sedation for things such as imaging or hematology/oncology procedures were included.  Propofol, dexmedetomidine, ketamine and opiates were the most commonly used agents.

AAEs included wheezing, secretions requiring treatment, cough, stridor, desaturations, obstruction, snoring, laryngospasm, and apnea.

 

Show References

Mallory et al.  Upper Respiratory Infections and Airway Adverse Events in Pediatric Procedural Sedation.  Pediatrics. 2017; 140 (1): 1-10.



Title: VTE in Pediatrics

Category: Pediatrics

Keywords: VTE, Thrombophilia, Enoxaparin, Children, Thromboembolism (PubMed Search)

Posted: 9/1/2017 by Megan Cobb, MD

Background:

There is an increased incidence of venous thromboembolic events (VTE) in pediatrics due to improved diagnosis and survival of children with VTE.

The mortality rate is estimated at 2%.

The most common etiologies vary by age - Central venous catheters in neonates and infants, and inherited thrombophilia in children and adolescents.

Learning Points:

  1. With neonates and infants, carefully assess medical history from neonatal period. Umbilical lines? PICC? Broviac? History of these is likely to be the cause.

  2. In children and adolescents, unprovoked VTE is most likely due to inherited thrombophilia, and can be DVT, PE, Portal venous thrombus, etc.

    1. Antithrombin deficiency: The first discovered inherited thrombophilia. The result is a lack of inhibition of coagulation factors – IIa, IXa, Xa, XIIa.

    2. Protein C or/and S deficiency: The result is lack of inhibition of activated Factor V.

    3. Factor V Leiden: Most common inherited thrombophilic defect. Resultant activated Factor V is resistant to normal Protein C and S activity.

    4. Prothrombin Mutation: Second most common inherited thrombophilia. The result is increased levels of prothrombin, which increases the half-life of factor Va.

  3. Initial treatment of clinically significant VTE can start with enoxaparin (1-1.5 mg/kg q12-24h, while checking Anti-Xa levels 4 hours after administration for therapeutic dosing.)

 

Pearl: Testing for thrombophilia is not always appropriate when diagnosing pediatric patients with their first VTE, but in children and adolescents with first diagnosed, unprovoked VTE, it is worthwhile to send off the initial hypercoaguability work up as this can affect the duration of treatment and need for testing or evaluation. Enoxaparin is a recommended medication to start therapeutic treatment of VTE, even in pediatric patients.

Show References

Van Ommen CH, Nowak-Gottl U. Inherited Thrombophilia in Pediatric Venous Thromboembolic Disease: Why and Who to Treat. Frontiers in Pediatrics. 2017: 5(20).

The Harriet Lane Handbook, 20th edition. Chapter 29: Drug Dosages. 2015



Title: What about Anaphylaxis in kids? (submitted by Yitschok Applebaum, MD)

Category: Pediatrics

Keywords: allergic reaction, anaphylaxis, auto-injector, epi-pen (PubMed Search)

Posted: 8/25/2017 by Mimi Lu, MD (Updated: 8/25/2017)

What if you were out in public and a 1 year old child (est 10 kg) suddenly develops anaphylaxis but you only have an epinephrine auto-injector with the “adult” dose of 0.3 mg.  Is it safe to give?

Anaphylaxis is a life threatening emergency with mortality of up to 2% [1]. Early recognition is imperative and administration of timely Epinephrine is the single most important intervention [2]. While providers may be hesitant to administer epinephrine in older patients due to fear of precipitating adverse cardiovascular events, they may also hesitate in younger patients due to fear of overdose. 

Iimmediate administration with any dose available is recommended because:

  • the risks of untreated anaphylaxis are greater than the risk of over-treating with epinephrine.
  • 20% of Anaphylaxis patients require a second dose of Epinephrine [3].
  • The recommended IM dose of 0.01mg /kg was determined arbitrarily.
  • The vast majority of epinephrine overdoses are via IV injection at doses 100 - 1000 fold the recommended  IV dose [4]

Bottom line:

There are no absolute contraindications (including age) for epinephrine in patients with anaphylaxis.  Give the initial dose IM into the anterolateral thigh.

Show References

1-  Bock SA, Muñoz-Furlong A, Sampson HA. Fatalities due to anaphylactic reactions to foods. J Allergy Clin Immunol. 2001 Jan. 107(1):191-3. [Medline].

2-  Sheikh A, Shehata YA, Brown SG, Simons FE. Adrenaline for the treatment of anaphylaxis: cochrane systematic review. Allergy 2009; 64:204.

3-  Oren E, Banerji A, Clark S, Camargo CA Jr. Food-induced anaphylaxis and repeated epinephrine treatments. Ann Allergy Asthma Immunol 2007; 99:429.

4-  Wood JP, Traub SJ, Lipinski C. Safety of epinephrine for anaphylaxis in the emergency setting. World Journal of Emergency Medicine. 2013;4(4):245-251. doi:10.5847/wjem.j.issn.1920-8642.2013.04.001.



Title: Bacterial Meningitis in Pediatric Complex Febrile Seizures

Category: Pediatrics

Keywords: Febrile seizure, meningitis (PubMed Search)

Posted: 8/18/2017 by Jenny Guyther, MD (Updated: 7/21/2026)

Febrile seizures occur in children 6 months through 5 year olds.  A complex febrile seizure occurs when the seizure is focal, prolonged (> 15 min), or occurs more than once in 24 hours.

The prevalence of bacterial meningitis in children with fever and seizure after the H flu and Strep pneumomoniae vaccine was introduced is 0.6% to 0.8%.  The prevalence of bacterial meningitis is 5x higher after a complex than simple seizure.

From the study referenced, those children with complex febrile seizures who had meningitis all had clinical exam findings suggestive of meningitis.  More studies are needed to provide definitive guidelines about when lumbar punctures are needed in these patients.

Show Additional Information

This study was a retrospective review of children aged 6 months to 5 years who had complex febrile seizures in France between 2007-2011.

Children were excluded if they had a simple febrile seizure, history of non-febrile seizure, conditions associated with a higher risk of seizure (cerebral malformations, genetic syndrome, trauma in the previous 24 hours) or predisposing to bacterial meningitis (sickle cell, cancer, immunosuppressive treatments).  Outcomes were the diagnosis of bacterial or HSV meningitis at 7 days

The rate of bacterial meningitis was 0.7% (CI 0.2-1.6).  There were no cases of HSV meningitis. 

69% of the study patients did not have a lumbar puncture, however, follow up was done by repeat exam, phone and review of the meningitis and also death registry if the patient was lost to follow up.

The clinical exam in the 5 children with bacterial meningitis was suggestive of meningitis (irritability, altered mental status, bulging fontanel).  In a subgroup of patients without physical exam findings suggestive of meningitis, there were no cases of bacterial meningitis.

 

 

Show References

Guedji R et al.  Do All Children Who Present With a Complex Febrile Seizure Need a Lumbar Puncture?  Annals of Emergency Medicine. 2017; 70 (1):52-62.



Title: Is there benefit to early oseltamivir in otherwise healthy pediatric patients with influenza? (Submitted by Sam Cordiero, MD)

Category: Pediatrics

Posted: 7/29/2017 by Mimi Lu, MD

The answer appears to be ... it depends.

Early Oseltamivir Treatment in Influenza in Children1-3 Years of Age: A Randomized Controlled Trial

A study in 2010 out of Finland by Heinonen, et al showed that if given in the first 12 hours of symptom onset to otherwise healthy pediatric patients between the age of 1-3 years:

-  decrease incidence of acute otitis media by 85%

-  no difference if given within 24 hours

Among children with influenza A, oseltamivir started within 24 hours of symptom onset

-  shortened medium time to resolution of illness by 3.5 days (3.0 versus 6.5) in all children

- shortened median time to resolution of illness by 4.0 days in UNvaccinated children

- Reduced parental work absenteeism by 3 days

*  no differences were seen in children with influenza B *

Limitations***

- Single Center study in Finland

- The authors received support from the drug manufacturer

- The sample size of children with confirmed influenza cases with small (influenza A: 79, influenza B: 19)

Takeaway:

If you have a patient between the age of 1-3 years with very early symptoms concerning for flu, a positive rapid influenza A test could allow you to cut her symptoms by 3 days, prevent complications, and allow parents to go back to work sooner.

 

Show Additional Information

Show References

Heinonen S, Silvennoinen H, Lehtinen  et al. Early oseltamivir treatment of influenza in children 1-3 years of age: A randomized controlled trial. Clin Infect Dis. 2010;51(8):87-94.



Title: Reducing radiation exposure in evaluation of ventricular shunt malfunctions in children

Category: Pediatrics

Keywords: CT scans, radiation exposure, pediatrics (PubMed Search)

Posted: 7/21/2017 by Jenny Guyther, MD (Updated: 7/21/2026)

Ventricular shunt (VP) malfunction can be severe and life-threatening and evaluation has typically included a dry CT brain and a shunt series which includes multiple x-rays of the skull, neck, chest and abdomen.  The goal of this study was to decrease the amount of radiation used in the evaluation of these patients since these patients will likely present many times over their lifetime.  Several institutions have more towards a rapid cranial MRI, however, this modality may not be readily available.

This multidisciplinary team decreased the CT scan radiation dose from 250mA (the reference mA in the pediatric protocol at this institution) to 150 mA which allows for a balance between reducing radiation exposure and adequate visualization of the ventricular system.  They also added single view chest and abdominal x-rays.

The authors found that after implementing this new protocol, there was a reduction in CT radiation doses and number of x-rays ordered with no change in the return rate.

 

Show References

Marchese et al.  Reduced Radiation in children presenting to the ED with Suspected Ventricular Shunt Complication.  Pediatrics. 2017; 139 (5).



Title: Pediatric Exposures to Veterinary Medications (submitted by Lauren Grandpre, MD)

Category: Pediatrics

Keywords: overdose, poisoning, veterinary medications (PubMed Search)

Posted: 6/24/2017 by Mimi Lu, MD

Every year in the U.S., preventable poisonings in children result in more than 60,000 ED visits and around 1 million calls to poison centers.  Calls relating specifically to pet medication exposure and children have been on the rise.

A recent study in Pediatrics was the first was kind to characterize the epidemiology of such exposures.

This study is a call to arms for an increased effort on the part of public health officials, pharmacists, veterinarians, and physicians to improve patient education to prevent these exposures from occurring. 

Summary of major findings:

  • Children less than or equal to age 5 are at greatest risk
  • Ingestion accounted for the exposure route in 93% of cases. 
  • Exploratory behavior(61.%) was the most common mechanism of exposure

Most commonly Implicated exposures:

  • Pet medications with no human equivalent  (17.3%)
  • Antimicrobials (14.8%
  • Antiparasitic 14.6%)
  • Analgesics (11.1%)

Key contributors to exposure risk:

  • Lack of recognition by caregivers of potential hazards of pet medications
  • Inappropriate or lack of home storage practices
  • Inconsistent compliance by veterinary providers in terms of proper product labeling and child-resistant packaging

Take home point: Make sure your pet's medications are appropriately stored for safety!

 

  •  

Show Additional Information

Methods involved reviewing regional Poison Control Center data from 1999 thruh 2013, during which 1431 calls regarding exposures of children less than or equal to age 19 or exposed to a veterinary medication. 

While the authors concluded that most exposures did not result in major adverse outcomes, 14.1% of exposures resulted in at least minor health effects.

A broader range of more highly toxic medications are increasingly being prescribed for animals, including anti-neoplastic drugs such as cyclophosphamide and chlorambucil.

Treatment of chronic health conditions and pets,  such as osteoarthritis, hypothyroidism, or anxiety is also increasingly common.

 

 

Show References

Tomasi S, Roberts KJ, Stull J, Spiller HA, McKenzie LB. Pediatric Exposures to Veterinary Pharmaceuticals. Pediatrics. 2017;139(3)



Title: Pediatric blunt trauma and the need for chest xray

Category: Pediatrics

Keywords: Blunt thoracic trauma, pediatric trauma, chest xray (PubMed Search)

Posted: 6/16/2017 by Jenny Guyther, MD

Chest injuries represent the second most common cause of pediatric trauma related death.  ATLS guidelines recommend CXR in all blunt trauma patients.  Previous studies have suggested a low risk of occult intrathoracic trauma; however, these studies included many children who were sent home.

Predictors of thoracic injury include: abdominal signs or symptoms (OR 7.7), thoracic signs of symptoms (OR 6), abnormal chest auscultation (OR 3.5), oxygen saturation < 95% (OR 3.1), BP < 5% for age (OR 3.7), and femur fracture (OR 2.5).

4.3 % of those found to have thoracic injuries did not have any of the above predictors, but their injuries were diagnosed on CXR.  These children did not require trauma related interventions.

Bottom line: There were still a number of children without these predictors that had thoracic injuries, so the authors suggest that chest xray should remain a part of pediatric trauma resuscitation.

Show Additional Information

This was a retrospective review of children aged 0-17 with blunt trauma requiring trauma team activation who had a chest xray preformed.  483 eligible children were included, all of whom were admitted to the hospital.  108 children had their thoracic injury detected on chest xray, 110 on chest CT and 76 on abdominal CT.  Pneumothorax, pulmonary contusion and multiple rib fractures were the most commonly found thoracic injuries.  All children also had other injuries.

Show References

Weerdenburg et al.  Predicting Thoracic Injury in Children with Multi-trauma.  Pediatric Emergency Care.  Epub ahead of print.  2017.



Title: Ziprasidone (Geodon) for acute agitation in pediatrics

Category: Pediatrics

Keywords: Psychiatric, agitation, pediatric (PubMed Search)

Posted: 5/19/2017 by Jenny Guyther, MD

IM ziprasidone (Geodon) has a relatively quick onset of action with a half-life of 2-5 hours.  Although commonly used in adults, there has not been a study looking at an effective dose in pediatrics. Based on the study referenced, the suggested pediatric dose of ziprasidone is 0.2 mg/kg (max 20mg).

Show Additional Information

This is the first study looking at ziprasidone in the pediatric emergency department population.  This was a retrospective observational study of children 5-18 years old who were treated with IM ziprasidone.  40 patients received IM ziprasidone in a tertiary care pediatric emergency department between 2007-2015.  2/3 of the patients had ADHD and 1/3 had autism spectrum disorder.  Other diagnosis included post-traumatic stress disorder, bipolar disorder and intellectual disabilities.

68% of patients responded to the initial dose.  The initial dose was 0.19 +/- 0.1 mg/kg in the responder group and 0.13 +/- 0.06 mg/kg in the non-responder group.  Single doses ranged from 2.5 mg to 20 mg total.

No patients had respiratory depression.  Two patients had potential extra-pyramidal symptoms, but one was prior to ziprasidone administration and the other patient had baseline facial twitching with no documentation if there was a change after ziprasidone administration.

Show References

Nguyen T, Stanton J and Foster R.  Intramuscular Ziprasidone Dosing for Acute Agitation in the Pediatric Emergency Department: An observational Study.  Journal of Pharmacy Practice 1-4.  2017.



Title: New FDA warning for codeine and tramadol in kids

Category: Pediatrics

Keywords: analgesics, Ultram, (PubMed Search)

Posted: 4/28/2017 by Mimi Lu, MD

The FDA recently announced restrictions on the use of Tramadol and Codeine in children and breastfeeding mothers due to possible harm in infants.  Essentially, codeine will now be contraindicated for the treatment of cough and/or pain, and tramadol contraindicated to treat pain for children under age 12 years. Tramadol will be also be contraindicated in children younger than 18 years for treatment of pain after tonssillectomy/ adenoidectomy. 
 
These medicines carry serious risks, including slowed or difficulty breathing and death. These medicines also should be limited in some older children.
 
Additional warnings apply for children 12 to 18 years who are obese, have severe lung disease, or sleep apnea as they may increase the risk of serious breathing problems. 
 
Please be aware of these new restrictions to protect the health and safety of our patients.
 
A summary statement from the American Hospital Association (AHA) is posted below.

Bottom line: Do not prescribe codeine or tramadol for cough or pain in children and breastfeeding moms.

Show Additional Information

A summary statement from the American Hospital Association (AHA) is posted below.

FDA RESTRICTS USE OF CODEINE AND TRAMADOL 
MEDICINES IN CHILDREN, RECOMMENDS AGAINST USE IN BREASTFEEDING MOTHERS

The Issue: 

The Food and Drug Administration (FDA) today announced that it is restricting the use of codeine and tramadol medicines in children, as well as recommending against using codeine and tramadol medicines in breastfeeding mothers due to possible harm to their infants.

Codeine is approved to treat pain and cough, and tramadol is approved to treat pain. These medicines carry serious risks, including slowed or difficult breathing and death, which appear to be a greater risk in children younger than 12 years, and should not be used in these children. These medicines also should be limited in some older children.

The FDA is requiring several changes to the labels of all prescription medicines containing these drugs. These new actions further limit the use of these medicines beyond FDA's 2013 restriction of codeine use in children younger than 18 years to treat pain after surgery to remove the tonsils and/or adenoids. The agency is now adding:

  • FDA's strongest warning, called a Contraindication, to the drug labels of codeine and tramadol alerting that codeine should not be used to treat pain or cough and tramadol should not be used to treat pain in children younger than 12 years.
  • A new Contraindication to the tramadol label warning against its use in children younger than 18 years to treat pain after surgery to remove the tonsils and/or adenoids.
  • A new Warning to the drug labels of codeine and tramadol to recommend against their use in adolescents between 12 and 18 years who are obese or have conditions such as obstructive sleep apnea or severe lung disease, which may increase the risk of serious breathing problems.
  • A strengthened Warning to mothers that breastfeeding is not recommended when taking codeine or tramadol medicines due to the risk of serious adverse reactions in breastfed infants. These can include excess sleepiness, difficulty breastfeeding or serious breathing problems that could result in death.

The FDA is urging health care professionals and patients to report side effects involving codeine-and tramadol-containing medicines to the FDA MedWatch program, through its online form. 

 



Title: Which children with bronchiolitis are at risk for developing asthma?

Category: Pediatrics

Keywords: Bronchiolitis, asthma (PubMed Search)

Posted: 4/21/2017 by Jenny Guyther, MD (Updated: 7/21/2026)

Predictive factors of asthma development in patients diagnosed with bronchiolitis include:

- Male sex (OR 1.3)

- Family history of asthma (OR 1.6)

- Age greater than 5 months at the time of bronchiolitis diagnosis (OR 1.4)

- More than 2 episodes of bronchiolitis (OR 2.4)

- Allergies (OR 1.6)

Show Additional Information

This was a retrospective study of 1991 children younger than 2 years that presented between 2000-2010 who were diagnosed with bronchiolitis.  Primary care records were reviewed 1 year after their visit to the ED to see if the patient had a primary care diagnosis of asthma. 

Of the initial study population, 817 patients had received a diagnosis of asthma at 1 year.

Since these patients were only followed up at 1 year, the amount of children who were later diagnosed with asthma may be underestimated.

Show References

Waseem et al.  Factors Predicting Asthma in children with Acute Bronchiolitis.  Pediatric Emergency Care.  March 2017.  Epub ahead of print.



Previous  |  1 |  ... |  6 |  7 |  8 |  9 |  10 |  11 |  12 |  13 |  14 |  15 |  16 |  ... |  28 |  Next
University of Maryland School of Medicine logo
  • Departments
  • Programs
  • Research Centers
  • Institutes
  • Graduate Education
  • CIBR Cores
  • Offices of the Dean
    • University of Maryland, Baltimore
    • University of Maryland Medical Center
    • Medical Alumni Association of the University of Maryland
    • Health Sciences and Human Services Library
University of Maryland School of Medicine
655 W. Baltimore Street
Baltimore, MD 21201
Contact Us

© University of Maryland School of Medicine

    • Webmaster
    • Web Accessibility
    • Site Index
    • UMB Hotline
    • Employment
    • Map